Regenative Labs Highlights Advancements in Post-Surgical Breast Reduction
Regenative Labs announces care advancements using Wharton’s jelly allografts in post-surgical breast reduction.
Regenative Labs announces care advancements using Wharton’s jelly allografts in post-surgical breast reduction.
Study results presented at EADV 2025 show nearly half of initial complete responders maintained clearance over four years.